Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Seraphina Therapeutics' FA15 Ingredient Advances to Finalist Status in NutraIngredients-USA Awards 2024: Redefining Healthy Aging


News provided by

Fatty15

May 30, 2024, 09:00 ET

Share this article

Share toX

Share this article

Share toX

The Pure C15:0 Ingredient in Fatty15 Outshines Leading Longevity Molecules, Showcasing Exceptional Ability to Slow Aging-Related Breakdown

SAN DIEGO, May 30, 2024 /PRNewswire-PRWeb/ --Seraphina Therapeutics is thrilled to announce that FA15, the pure C15:0 ingredient in the groundbreaking supplement, fatty15, has been selected as a finalist in the prestigious 2024 NutraIngredients Awards' Ingredient of the Year in Healthy Aging. FA15™ has distinguished itself as a leader in the ingredient industry, showcasing exceptional ability to promote healthy aging.

With global populations aging rapidly and a growing demographic of individuals over 50 years old, the demand for healthy aging nutritional solutions has surged. NutraIngredients' Ingredient of the Year: Healthy Aging category is dedicated to recognizing the finest contributions in the industry aimed at helping people maintain physical and mental health as they age.

"Seraphina Therapeutics continues to forge new paths for healthy aging by leveraging our pure C15:0 ingredient that is truly essential for long-term health," shared Dr. Stephanie Venn-Watson, co-founder and CEO of Seraphina. "We are honored to be recognized by the NutraIngredients-USA Awards once again, first as a trailblazing Startup company, and now in the category of Healthy Aging."

FA15™, the pure C15:0 ingredient found in fatty15, has emerged as a groundbreaking solution in the healthy aging space. While helping to continually improve the health of Navy dolphins, Dr. Venn-Watson initially discovered that the healthiest aging dolphins had higher dietary and circulating C15:0 (pentadecanoic acid) levels. C15:0 is an odd-chain saturated fatty acid primarily present in trace levels in dairy fat, as well as some types of fish, meat, and plants.

Over the past 10 years, Dr. Venn-Watson's studies have uncovered C15:0 as the first essential fatty acid to be discovered in over 90 years, since omega-3. With 36+ cellular benefits, studies have shown that FA15 has three times more benefits than pure omega-3 (EPA), as well as more cellular benefits than leading longevity-enhancing molecules, including rapamycin and metformin.

"By providing a high quality, vegan-friendly and pure C15:0 ingredient, FA15™ was developed to have greater health promoting capabilities than food-based C15:0," said Dr. Venn-Watson. In nature, our primary source of C15:0 is from dairy fat, which contains much higher levels of pro-inflammatory even-chain saturated fatty acids. Seraphina Therapeutics' approach to advancing C15:0 as a pure healthy aging ingredient follows guidance from a prestigious panel of nutritional scientists who concluded that active ingredients within milkfat are more effective in isolation compared to when mixed in whole food. "While we are used to hearing that nutrients are best garnered from whole foods, it is now understood that active ingredients from dairy fat can be an exception to that general rule," said Dr. Venn-Watson.

FA15 supports healthy aging by strengthening cell membranes against age-related breakdown. In addition, it targets 6 out of 12 hallmarks of aging (including inflammaging, mitochondrial dysfunction, and senescent "zombie" cells) which are mechanisms that define how we age at the cellular level. Further, research indicates that C15:0 actively contributes to slowing down the aging process via:

  • Longevity-supportive signaling: C15:0 activates AMPK and inhibits mTOR, a key means to enhance longevity.
  • Outperforming leading longevity molecules: In comparative studies, C15:0 has shown more cellular health benefits compared to leading longevity-enhancing candidate molecules like rapamycin and metformin.
  • Direct supplementation: C15:0 supplementation not only increases total C15:0 blood levels but also enhances the presence of lysophosphatidylethanolamide (LPE) containing C15:0, the very lipid species linked to slower biological aging.
  • Reversing aging markers: Studies show that C15:0 supplementation stabilizes cells and reverses declining hemoglobin, effectively slowing down a key biomarker of aging rate.

The recent NutraIngredients Awards recognition is one of a growing list of accolades for FA15™ and fatty15, which has included Nutritional Outlook's Best of the Industry Award: Best Ingredient (2021), NutraIngredients Awards Finalist for Best Startup (2021), and Fast Company's World Changing Ideas in Wellness (2022 and 2024).

About Seraphina Therapeutics. Inc.
Seraphina Therapeutics, Inc. is a health and wellness company dedicated to advancing global health through the discovery of essential fatty acids and micronutrient therapeutics. Through rigorous breakthrough science, the company develops fatty acid supplements, food fortifiers, and nutritional interventions to strengthen cells, keep mitochondria working and advance cellular homeostasis to counter age-related breakdown. With its team of industry-leading scientists, Seraphina Therapeutics challenges long-held approaches to nutrition, enabling the creation of novel health products designed to support quality of life. For more information, please visit DiscoverC15.com and fatty15.com.

Media Contact

Fatty15 Press Office, Fatty15, 1 619-407-9225, [email protected], fatty15.com

SOURCE Fatty15

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.